[TREATMENT TRIALS IN PULMONARY TUBERCULOSIS COMBINING ISONIAZID, ADMINISTERED 2 TIMES A WEEK, AND A THIOCARBANILIDE IN DAILY FORM].
D000813:Anilides; D000995:Antitubercular Agents; D035843:Biomedical Research; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D007538:Isoniazid; D010670:Phenylthiourea / Q000031:analogs & derivatives; D014116:Toxicology; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary
D000813:Anilides; D000995:Antitubercular Agents; C100189:thiocarlide; D010670:Phenylthiourea; D007538:Isoniazid
ANILIDES; ANTITUBERCULAR AGENTS; CLINICAL RESEARCH; DRUG RESISTANCE, MICROBIAL; ISONIAZID; THIOCARLIDE; TOXICOLOGIC REPORT; TUBERCULOSIS, PULMONARY
ENSAYOS DE TRATAMIENTO ASOCIADO DE LA TUBERCULOSIS PULMONARY CON ISONIACIDA ADMINISTRADA DOS VECES POR SEMANA Y UNA TIOCARBANIILIDA EN FORMA DIARIA.